ann out: atl1101 eu patent grant, page-52

I don't see the patent grant as justification for a significant re-rating. It should be taken as another positive sign of where we are headed though. How people manage to spin it into a negative is beyond me. The price may stay the same, but I doubt it will drop below 1.5c

Consider, for a moment, exactly what 1.7 cents gets you:

- ATL1103 entering Phase 2 with explicit interest from an international pharma

- ATL1102 fully funded by a Chinese Biotech Academy with a shot at the Chinese market

- ATL1101 for cancer. Enough said.

- Collaboration with a Big Brother in the US (ISIS) breaking new highs and soon to be validating antisense technology

- Operating cash and working capital well into 2014

I'm pretty happy with what 1.7 cents gets me. Patience is key.